2021年4期
Journal of Pharmaceutical Analysis
- Reducing SARS-CoV-2 pathological protein activity with small molecules
- Development of the general chapters of the Chinese Pharmacopoeia 2020 edition: A review
- Liquid chromatographic methods for determination of the new antiepileptic drugs stiripentol, retigabine, rufinamide and perampanel: A comprehensive and critical review
- Biocompatible silver nanoparticles:An investigation into their protein binding efficacies, anti-bacterial effects and cell cytotoxicity studies
- Comparative permeability of three saikosaponins and corresponding saikogenins in Caco-2 model by a validated UHPLC-MS/MS method
- Simultaneous determination of fourteen components of Gumiganghwal-tang tablet in human plasma by UPLC-ESI-MS/MS and its application to pharmacokinetic study
- UHPLC-MS/MS analysis of cAMP and cGMP in rat plasma as potential biomarkers of Yin-Yang disharmony in traditional Chinese medicine
- Determination of bioactive components in the fruits of Cercis chinensis Bunge by HPLC-MS/MS and quality evaluation by principal components and hierarchical cluster analyses
- Liquid chromatography-mass spectrometry method for the quantification of an anti-sclerostin monoclonal antibody in cynomolgus monkey serum
- Formation mechanisms of sub-micron pharmaceutical composite particles derived from far- and near-field Raman microscopy
- Portable and automated analyzer for rapid and high precision in vitro dissolution of drugs
- Matrix-assisted laser desorption ionization mass spectrometry based quantitative analysis of cordycepin from Cordyceps militaris
- Plasma-metabolite-based machine learning is a promising diagnostic approach for esophageal squamous cell carcinoma investigation
- Visualization analysis of lecithin in drugs based on electrochemiluminescent single gold microbeads
- A simplified LC-MS/MS method for the quantification of the cardiovascular disease biomarker trimethylamine-N-oxide and its precursors